BNP Paribas Financial Markets’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$76.9K Sell
6,797
-2,846
-30% -$27.9K ﹤0.01% 4687
2026
Q1
$60.8K Sell
9,643
-92
-0.9% -$829 ﹤0.01% 4596
2025
Q4
$104K Buy
9,735
+901
+10% +$9.9K ﹤0.01% 4354
2025
Q3
$110K Sell
8,834
-2,617
-23% -$26.8K ﹤0.01% 4253
2025
Q2
$117K Buy
11,451
+2,111
+23% +$18.6K ﹤0.01% 3964
2025
Q1
$73.8K Buy
9,340
+3,965
+74% +$48.8K ﹤0.01% 4152
2024
Q4
$42.2K Buy
+5,375
New +$27K ﹤0.01% 4492

Other funds holding CRNC

BNP Paribas Financial Markets's CRNC Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Cerence (CRNC) stake by 30% in Q2 2026, selling an estimated $27.9K and leaving 6,797 shares worth $76.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4687.

BNP Paribas Financial Markets first reported a position in CRNC in Q4 2024 and has held it in 7 quarters since. The position peaked at $117K in Q2 2025. 178 funds tracked by Wall St. Rank hold CRNC as of Q2 2026.

  • BNP Paribas Financial Markets held 6,797 shares of Cerence worth $76.9K as of Q2 2026.
  • BNP Paribas Financial Markets sold 2,846 Cerence shares in Q2 2026, an estimated $27.9K.
  • Cerence made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4687 holding.
  • BNP Paribas Financial Markets first reported a position in Cerence in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Cerence position peaked at $117K in Q2 2025.
  • 178 funds tracked by Wall St. Rank held Cerence as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.